Refine
Year of publication
Document Type
- Article (59)
- Doctoral Thesis (1)
Language
- English (60)
Has Fulltext
- yes (60)
Is part of the Bibliography
- no (60)
Keywords
- macrophage (8)
- inflammation (7)
- cancer (6)
- sphingosine-1-phosphate (6)
- tumor microenvironment (6)
- macrophage polarization (4)
- psoriasis (4)
- apoptosis (3)
- lung cancer (3)
- Breast cancer (2)
- Breast tumors (2)
- Immunology (2)
- Macrophages (2)
- NADPH oxidase (2)
- Nox1 (2)
- NoxO1 (2)
- Reactive oxygen species (2)
- angiogenesis (2)
- cancer-associated fibroblasts (2)
- colon (2)
- immunotherapy (2)
- lipocalin-2 (2)
- macrophages (2)
- mammary carcinoma (2)
- proliferation (2)
- reactive oxygen species (2)
- 3T3-L1 mouse fibroblasts (1)
- AGMO (1)
- Acute inflammation (1)
- Apoptosis (1)
- CD47 (1)
- COVID-19 (1)
- Cancer (1)
- Carcinogenese (1)
- Carotid injury (1)
- Cell binding (1)
- Cell death and immune response (1)
- Cell staining (1)
- Cytoskeleton (1)
- DNA methylation (1)
- Dermatitis (1)
- Ena/VASP proteins (1)
- Extracellular vesicles (1)
- Flow cytometry (1)
- G2A (1)
- GEMs (1)
- GPCR (1)
- Gene expression (1)
- Glycolysis (1)
- HCC marker (1)
- HIF-2 (1)
- Hepatocellular carcinoma (1)
- Hepatotoxicity (1)
- Hypoxia (1)
- IAP (1)
- IFN-β (1)
- IKKε (1)
- IL-1β (1)
- IL-27 cytokine (1)
- IL-33 (1)
- Immune cells (1)
- Inflammation (1)
- Iron (1)
- Jurkat (1)
- Kupffer cells (1)
- LASS (1)
- LDHB (1)
- Makrophage (1)
- Messenger RNA (1)
- Mitochondrial ROS (1)
- Mouse models (1)
- Mφs (1)
- NF-кB (1)
- NLRP3 inflammasomes (1)
- Nox4 (1)
- Oxidative phosphorylation (1)
- PD-L1 (1)
- Peritoneal macrophages (1)
- Physiology (1)
- Polyunsaturated fatty acid mediators (1)
- Psoriasis (1)
- RNA extraction (1)
- RNA isolation (1)
- RNA sequencing (1)
- RNA therapeutics (1)
- Restenosis (1)
- S1PR1 (1)
- S1PR4 (1)
- SARS-CoV-2 (1)
- SIRPalpha (1)
- SMAD (1)
- STAT1 (1)
- Single-cell RNA sequencing (1)
- Soluble epoxide hydrolase (1)
- Sphingolipidstoffwechsel (1)
- Superoxide (1)
- T-cell (1)
- TBK1 (1)
- TGFβ (1)
- VEGF receptor 2 internalization and signaling (1)
- Zymosan-induced peritonitis (1)
- acute inflammation (1)
- adenocarcinoma (1)
- adipocytes (1)
- alcoholic hepatitis (1)
- amlexanox (1)
- antiviral therapy (1)
- apoptotic cells (1)
- arachidonate 12/15-lipoxygenase (Alox12/15) (1)
- atherosclerosis (1)
- breast cancer (1)
- breast tumor (1)
- cancer metastases (1)
- ceramide synthase (1)
- chemokines (1)
- chemotherapy (1)
- compound screen (1)
- coronavirus (1)
- costimulation (1)
- cytokine (1)
- cytokine, angiogenesis (1)
- cytotoxic T cells (1)
- cytotoxic T lymphocyte (1)
- cytotoxic lymphocytes (1)
- cytotoxicity (1)
- diabetic nephropathy (1)
- diffusion-weighted magnetic resonance imaging (1)
- drug discovery (1)
- efferocytosis (1)
- endothelial cell (1)
- endothelial cells (1)
- enzyme activity assay (1)
- extracellular matrix (1)
- fatty acid (1)
- ferroportin (1)
- flow cytometry (1)
- gene expression (1)
- gene signature (1)
- hierarchical clustering (1)
- hypoxia (1)
- imiquimod (1)
- immune checkpoint (1)
- immunity (1)
- infection (1)
- interferon regulatory factor 9 (IRF9) (1)
- inflammation (1)
- iron (1)
- iron-trafficking (1)
- lipids (1)
- lipoxin A4 (1)
- liver (1)
- liver X receptor (1)
- lung tumor heterogeneity (1)
- lymphangiogenesis (1)
- mTORC (1)
- mammary cancer (1)
- mast cells (1)
- matrix metalloproteinase (1)
- melanoma (1)
- metabolism (1)
- metastasis (1)
- miR (1)
- microenvironment (1)
- migration (1)
- multiplexed immunofluorescence (1)
- multispectral flow cytometry (1)
- natural killer T cells (1)
- neoadjuvant chemoradiotherapy (1)
- nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2) (1)
- oral cavity cancer (1)
- oxidative stress (1)
- p47phox (1)
- pain (1)
- peritoneal macrophages (1)
- peroxisome proliferator-activated receptor (1)
- phagocytosis (1)
- polarization (1)
- polyunsaturated fatty acid (1)
- predictive biomarker (1)
- prostaglandins (1)
- protein-protein interaction (1)
- rapamycin (1)
- renal cell carcinoma (1)
- resolution (1)
- resolution of inflammation (1)
- sepsis (1)
- signal transduction (1)
- specialized pro-resolving lipid mediators (SPMs) (1)
- sphingolipids (1)
- sprouting angiogenesis (1)
- tetrahydrobiopterin (1)
- tip cell filopodia formation (1)
- toll-like receptor (1)
- transcriptional profiling (1)
- transcriptome (1)
- tumor (1)
- tumor development (1)
- tumor growth (1)
- tumor immunity (1)
- tumor microenvironment (TME) (1)
- tumor progression (1)
- tumor stroma (1)
- tumor-associated macrophages (1)
- tumor-associated macrophages (TAM) (1)
- type I interferons (IFNs) (1)
- versican (VCAN) (1)
Institute
Macrophages are highly versatile cells, which acquire, depending on their microenvironment, pro- (M1-like), or antiinflammatory (M2-like) phenotypes. Here, we studied the role of the G-protein coupled receptor G2A (GPR132), in chemotactic migration and polarization of macrophages, using the zymosan-model of acute inflammation. G2A-deficient mice showed a reduced zymosan-induced thermal hyperalgesia, which was reversed after macrophage depletion. Fittingly, the number of M1-like macrophages was reduced in the inflamed tissue in G2A-deficient mice. However, G2A activation was not sufficient to promote M1-polarization in bone marrow-derived macrophages. While the number of monocyte-derived macrophages in the inflamed paw was not altered, G2A-deficient mice had less macrophages in the direct vicinity of the origin of inflammation, an area marked by the presence of zymosan, neutrophil accumulation and proinflammatory cytokines. Fittingly neutrophil efferocytosis was decreased in G2A-deficient mice and several lipids, which are released by neutrophils and promote G2A-mediated chemotaxis, were increased in the inflamed tissue. Taken together, G2A is necessary to position macrophages in the proinflammatory microenvironment surrounding the center of inflammation. In absence of G2A the macrophages are localized in an antiinflammatory microenvironment and macrophage polarization is shifted toward M2-like macrophages.
Alkylglycerol monooxygenase (AGMO) is a tetrahydrobiopterin (BH4)-dependent enzyme with major expression in the liver and white adipose tissue that cleaves alkyl ether glycerolipids. The present study describes the disclosure and biological characterization of a candidate compound (Cp6), which inhibits AGMO with an IC50 of 30–100 µM and 5–20-fold preference of AGMO relative to other BH4-dependent enzymes, i.e., phenylalanine-hydroxylase and nitric oxide synthase. The viability and metabolic activity of mouse 3T3-L1 fibroblasts, HepG2 human hepatocytes and mouse RAW264.7 macrophages were not affected up to 10-fold of the IC50. However, Cp6 reversibly inhibited the differentiation of 3T3-L1 cells towards adipocytes, in which AGMO expression was upregulated upon differentiation. Cp6 reduced the accumulation of lipid droplets in adipocytes upon differentiation and in HepG2 cells exposed to free fatty acids. Cp6 also inhibited IL-4-driven differentiation of RAW264.7 macrophages towards M2-like macrophages, which serve as adipocyte progenitors in adipose tissue. Collectively, the data suggest that pharmacologic AGMO inhibition may affect lipid storage.
The interaction of macrophages with apoptotic cells is required for efficient resolution of inflammation. While apoptotic cell removal prevents inflammation due to secondary necrosis, it also alters the macrophage phenotype to hinder further inflammatory reactions. The interaction between apoptotic cells and macrophages is often studied by chemical or biological induction of apoptosis, which may introduce artifacts by affecting the macrophages as well and/or triggering unrelated signaling pathways. Here, we set up a pure cell death system in which NIH 3T3 cells expressing dimerizable Caspase-8 were co-cultured with peritoneal macrophages in a transwell system. Phenotype changes in macrophages induced by apoptotic cells were evaluated by RNA sequencing, which revealed an unexpectedly dominant impact on macrophage proliferation. This was confirmed in functional assays with primary peritoneal macrophages and IC-21 macrophages. Moreover, inhibition of apoptosis during Zymosan-induced peritonitis in mice decreased mRNA levels of cell cycle mediators in peritoneal macrophages. Proliferation of macrophages in response to apoptotic cells may be important to increase macrophage numbers in order to allow efficient clearance and resolution of inflammation.
IL-27 regulates inflammatory diseases by exerting a pleiotropic impact on immune cells. In cancer, IL-27 restricts tumor growth by acting on tumor cells directly, while its role in the tumor microenvironment is still controversially discussed. To explore IL-27 signaling in the tumor stroma, we used a mammary carcinoma syngraft approach in IL27Rα-deficient mice. Tumor growth in animals lacking IL27Rα was markedly reduced. We noticed a decrease in immune cell infiltrates, enhanced tumor cell death, and fibroblast accumulation. However, most striking changes pertain the tumor vasculature. Tumors in IL27Rα-deficient mice were unable to form functional vessels. Blocking IL-27-STAT1 signaling in endothelial cells in vitro provoked an overshooting migration/sprouting of endothelial cells. Apparently, the lack of the IL-27 receptor caused endothelial cell hyper-activation via STAT1 that limited vessel maturation. Our data reveal a so far unappreciated role of IL-27 in endothelial cells with importance in pathological vessel formation.
Epoxides and diols of polyunsaturated fatty acids (PUFAs) are bioactive and can influence processes such as tumor cell proliferation and angiogenesis. Studies with inhibitors of the soluble epoxide hydrolase (sEH) in animals overexpressing cytochrome P450 enzymes or following the systemic administration of specific epoxides revealed a markedly increased incidence of tumor metastases. To determine whether PUFA epoxides increased metastases in a model of spontaneous breast cancer, sEH-/- mice were crossed onto the polyoma middle T oncogene (PyMT) background. We found that the deletion of the sEH accelerated the growth of primary tumors and increased both the tumor macrophage count and angiogenesis. There were small differences in the epoxide/diol content of tumors, particularly in epoxyoctadecamonoenic acid versus dihydroxyoctadecenoic acid, and marked changes in the expression of proteins linked with cell proliferation and metabolism. However, there was no consequence of sEH inhibition on the formation of metastases in the lymph node or lung. Taken together, our results confirm previous reports of increased tumor growth in animals lacking sEH but fail to substantiate reports of enhanced lymph node or pulmonary metastases.
Role of the soluble epoxide hydrolase in the hair follicle stem cell homeostasis and hair growth
(2022)
Polyunsaturated fatty acids (PUFAs) are used as traditional remedies to treat hair loss, but the mechanisms underlying their beneficial effects are not well understood. Here, we explored the role of PUFA metabolites generated by the cytochrome P450/soluble epoxide hydrolase (sEH) pathway in the regulation of the hair follicle cycle. Histological analysis of the skin from wild-type and sEH−/− mice revealed that sEH deletion delayed telogen to anagen transition, and the associated activation of hair follicle stem cells. Interestingly, EdU labeling during the late anagen stage revealed that hair matrix cells from sEH−/− mice proliferated at a greater rate which translated into increased hair growth. Similar effects were observed in in vitro studies using hair follicle explants, where a sEH inhibitor was also able to augment whisker growth in follicles from wild-type mice. sEH activity in the dorsal skin was not constant but altered with the cell cycle, having the most prominent effects on levels of the linoleic acid derivatives 12,13-epoxyoctadecenoic acid (12,13-EpOME), and 12,13-dihydroxyoctadecenoic acid (12,13-DiHOME). Fitting with this, the sEH substrate 12,13-EpOME significantly increased hair shaft growth in isolated anagen stage hair follicles, while its diol; 12,13-DiHOME, had no effect. RNA sequencing of isolated hair matrix cells implicated altered Wnt signaling in the changes associated with sEH deletion. Taken together, our data indicate that the activity of the sEH in hair follicle changes during the hair follicle cycle and impacts on two stem cell populations, i.e., hair follicle stem cells and matrix cells to affect telogen to anagen transition and hair growth.
In ischemic vascular diseases, leukocyte recruitment and polarization are crucial for revascularization and tissue repair. We investigated the role of vasodilator-stimulated phosphoprotein (VASP) in vascular repair. After hindlimb ischemia induction, blood flow recovery, angiogenesis, arteriogenesis, and leukocyte infiltration into ischemic muscles in VASP−/− mice were accelerated. VASP deficiency also elevated the polarization of the macrophages through increased signal transducer and activator of transcription (STAT) signaling, which augmented the release of chemokines, cytokines, and growth factors to promote leukocyte recruitment and vascular repair. Importantly, VASP deletion in bone marrow–derived cells was sufficient to mimic the increased blood flow recovery of global VASP−/− mice. In chemotaxis experiments, VASP−/− neutrophils/monocytes were significantly more responsive to M1-related chemokines than wild-type controls. Mechanistically, VASP formed complexes with the chemokine receptor CCR2 and β-arrestin-2, and CCR2 receptor internalization was significantly reduced in VASP−/− leukocytes. Our data indicate that VASP is a major regulator of leukocyte recruitment and polarization in postischemic revascularization and support a novel role of VASP in chemokine receptor trafficking.
Aim: NADPH oxidases are important sources of reactive oxygen species (ROS). Several Nox homologues are present together in the vascular system but whether they exhibit crosstalk at the activity level is unknown. To address this, vessel function of knockout mice for the cytosolic Nox organizer proteins p47phox, NoxO1 and a p47phox-NoxO1-double knockout were studied under normal condition and during streptozotocin-induced diabetes.
Results: In the mouse aorta, mRNA expression for NoxO1 was predominant in smooth muscle and endothelial cells, whereas p47phox was markedly expressed in adventitial cells comprising leukocytes and tissue resident macrophages. Knockout of either NoxO1 or p47phox resulted in lower basal blood pressure. Deletion of any of the two subunits also prevented diabetes-induced vascular dysfunction. mRNA expression analysis by MACE (Massive Analysis of cDNA ends) identified substantial gene expression differences between the mouse lines and in response to diabetes. Deletion of p47phox induced inflammatory activation with increased markers of myeloid cells and cytokine and chemokine induction. In contrast, deletion of NoxO1 resulted in an attenuated interferon gamma signature and reduced expression of genes related to antigen presentation. This aspect was also reflected by a reduced number of circulating lymphocytes in NoxO1-/- mice.
Innovation and conclusion: ROS production stimulated by NoxO1 and p47phox limit endothelium-dependent relaxation and maintain blood pressure in mice. However, NoxO1 and p47phox cannot substitute each other despite their similar effect on vascular function. Deletion of NoxO1 induced an anti-inflammatory phenotype, whereas p47phox deletion rather elicited a hyper-inflammatory response.
Endothelial tip cells are essential for VEGF-induced angiogenesis, but underlying mechanisms are elusive. The Ena/VASP protein family, consisting of EVL, VASP, and Mena, plays a pivotal role in axon guidance. Given that axonal growth cones and endothelial tip cells share many common features, from the morphological to the molecular level, we investigated the role of Ena/VASP proteins in angiogenesis. EVL and VASP, but not Mena, are expressed in endothelial cells of the postnatal mouse retina. Global deletion of EVL (but not VASP) compromises the radial sprouting of the vascular plexus in mice. Similarly, endothelial-specific EVL deletion compromises the radial sprouting of the vascular plexus and reduces the endothelial tip cell density and filopodia formation. Gene sets involved in blood vessel development and angiogenesis are down-regulated in EVL-deficient P5-retinal endothelial cells. Consistently, EVL deletion impairs VEGF-induced endothelial cell proliferation and sprouting, and reduces the internalization and phosphorylation of VEGF receptor 2 and its downstream signaling via the MAPK/ERK pathway. Together, we show that endothelial EVL regulates sprouting angiogenesis via VEGF receptor-2 internalization and signaling.
Objective: The NADPH oxidase Nox4 is an important source of H2O2. Nox4-derived H2O2 limits vascular inflammation and promotes smooth muscle differentiation. On this basis, the role of Nox4 for restenosis development was determined in the mouse carotid artery injury model. Methods and results: Genetic deletion of Nox4 by a tamoxifen-activated Cre-Lox-system did not impact on neointima formation in the carotid artery wire injury model. To understand this unexpected finding, time-resolved single-cell RNA-sequencing (scRNAseq) from injured carotid arteries of control mice and massive-analysis-of-cDNA-ends (MACE)-RNAseq from the neointima harvested by laser capture microdissection of control and Nox4 knockout mice was performed. This revealed that resting smooth muscle cells (SMCs) and fibroblasts exhibit high Nox4 expression, but that the proliferating de-differentiated SMCs, which give rise to the neointima, have low Nox4 expression. In line with this, the first weeks after injury, gene expression was unchanged between the carotid artery neointimas of control and Nox4 knockout mice. Conclusion: Upon vascular injury, Nox4 expression is transiently lost in the cells which comprise the neointima. NADPH oxidase 4 therefore does not interfere with restenosis development after wire-induced vascular injury.